BIOMAT Database Logo BIOMAT Database Logo

An antagonistic activity of etizolam on platelet-activating factor (PAF). In vitro effects on platelet aggregation and PAF receptor binding. 1987

H Mikashima, and S Takehara, and Y Muramoto, and T Khomaru, and M Terasawa, and T Tahara, and Y Maruyama
Research Laboratories, Yoshitomi Pharmaceutical Industries, Ltd., Fukuoka, Japan.

The antagonistic effect of etizolam, an anti-anxiety drug, on platelet-activating factor (PAF) was investigated in rabbit platelets in vitro. Etizolam inhibited PAF-induced aggregation in a dose-dependent manner, with an IC50 of 3.8 microM, about one tenth that of triazolam (IC50 = 30 microM). At 300 microM, it inhibited both ADP and arachidonic acid-induced aggregation only slightly, while the other anti-anxiety drugs tested had no effect on PAF-induced aggregation even at this concentration. Etizolam and triazolam inhibited the specific binding of 3H-PAF to PAF receptor sites on washed rabbit platelets with IC50 values of 22 nM and 320 nM, respectively. Diazepam and estazolam were inactive even at 1 microM. These results indicate that etizolam is a specific antagonist of PAF.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010980 Platelet Membrane Glycoproteins Surface glycoproteins on platelets which have a key role in hemostasis and thrombosis such as platelet adhesion and aggregation. Many of these are receptors. PM-GP,Platelet Glycoprotein,Platelet Membrane Glycoprotein,PM-GPs,Platelet Glycoproteins,Glycoprotein, Platelet,Glycoprotein, Platelet Membrane,Glycoproteins, Platelet,Glycoproteins, Platelet Membrane,Membrane Glycoprotein, Platelet,Membrane Glycoproteins, Platelet,PM GP
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014149 Tranquilizing Agents A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes. Ataractics,Tranquilizing Drugs,Tranquilizing Effect,Tranquilizing Effects,Tranquillizing Agents,Tranquillizing Drugs,Agents, Tranquilizing,Agents, Tranquillizing,Drugs, Tranquilizing,Drugs, Tranquillizing,Effect, Tranquilizing,Effects, Tranquilizing

Related Publications

H Mikashima, and S Takehara, and Y Muramoto, and T Khomaru, and M Terasawa, and T Tahara, and Y Maruyama
Antagonistic activity of etizolam on platelet-activating factor in vivo experiments.
August 1987, Japanese journal of pharmacology,
H Mikashima, and S Takehara, and Y Muramoto, and T Khomaru, and M Terasawa, and T Tahara, and Y Maruyama
Platelet-activating factor (PAF), a mediator of platelet aggregation. Effect of corticosteroids on PAF-induced platelet aggregation.
January 1980, Minerva nefrologica,
H Mikashima, and S Takehara, and Y Muramoto, and T Khomaru, and M Terasawa, and T Tahara, and Y Maruyama
Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity.
January 1987, British journal of pharmacology,
H Mikashima, and S Takehara, and Y Muramoto, and T Khomaru, and M Terasawa, and T Tahara, and Y Maruyama
Platelet-activating factor (PAF) receptor-binding antagonist activity of Malaysian medicinal plants.
January 2005, Phytomedicine : international journal of phytotherapy and phytopharmacology,
H Mikashima, and S Takehara, and Y Muramoto, and T Khomaru, and M Terasawa, and T Tahara, and Y Maruyama
Antibodies to platelet-activating factor (PAF) inhibit PAF-induced platelet aggregation.
November 1991, Journal of lipid mediators,
H Mikashima, and S Takehara, and Y Muramoto, and T Khomaru, and M Terasawa, and T Tahara, and Y Maruyama
In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
January 2000, Veterinary research,
H Mikashima, and S Takehara, and Y Muramoto, and T Khomaru, and M Terasawa, and T Tahara, and Y Maruyama
Antiplatelet aggregation and platelet activating factor (PAF) receptor antagonistic activities of the essential oils of five Goniothalamus species.
July 2010, Molecules (Basel, Switzerland),
H Mikashima, and S Takehara, and Y Muramoto, and T Khomaru, and M Terasawa, and T Tahara, and Y Maruyama
Structure-activity relationships in platelet-activating factor (PAF). 5. Synthesis and in vitro antagonistic activities of ketophosphonates.
January 1991, Journal of lipid mediators,
H Mikashima, and S Takehara, and Y Muramoto, and T Khomaru, and M Terasawa, and T Tahara, and Y Maruyama
Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum.
March 2012, Pharmaceutical biology,
H Mikashima, and S Takehara, and Y Muramoto, and T Khomaru, and M Terasawa, and T Tahara, and Y Maruyama
Platelet-activating factor (PAF) receptor binding antagonists from Alpinia officinarum.
December 2007, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!